Načítá se...
Case series of six kidney transplanted patients with COVID‐19 pneumonia treated with tocilizumab
Few reports described the outcome of kidney transplanted patients (KTs) affected by COVID‐19 treated with interleukin‐6 receptor inhibitor tocilizumab (TCZ). We report our case series of 6 KTs with COVID‐19 pneumonia who received TCZ: All were of male gender, with a mean age of 55.5 ± 8.4 years, a m...
Uloženo v:
| Vydáno v: | Transpl Infect Dis |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300504/ https://ncbi.nlm.nih.gov/pubmed/32500936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.13348 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|